Literature DB >> 13814393

A permeability factor released from guinea-pig serum by antigen-antibody precipitates.

G E DAVIES, J S LOWE.   

Abstract

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; CAPILLARY PERMEABILITY

Mesh：

Year:  1960        PMID： 13814393      PMCID： PMC2083196     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  8 in total

1.  Elution of an esterase from antigen-antibody aggregates treated with human complement.

Authors:  I H LEPOW; O D RATNOFF; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

2.  Development of pain-producing substance in human plasma.

Authors:  D ARMSTRONG; C A KEELE; J B JEPSON; J W STEWART
Journal:  Nature       Date:  1954-10-23       Impact factor: 49.962

3.  The role of histamine in cutaneous antigen-antibody reactions in the rat.

Authors:  W E BROCKLEHURST; J H HUMPHREY; W L PERRY
Journal:  J Physiol       Date:  1955-08-29       Impact factor: 5.182

4.  Anaphylatoxin, histamine depletion and skin reactions in the rat.

Authors:  M ROCHA E SILVA; A M ROTHSCHILD
Journal:  Nature       Date:  1955-06-04       Impact factor: 49.962

5.  Histamine release from the perfused lung of the guinea pig by serotoxin, anaphylatoxin.

Authors:  M ROCHA E SILVA; M ARONSON
Journal:  Br J Exp Pathol       Date:  1952-12

6.  The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins.

Authors:  J H GADDUM; E W HORTON
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  The biological activity of soluble antigen-antibody complexes. II. Physical properties of soluble complexes having skin-irritating activity.

Authors:  K ISHIZAKA; T ISHIZAKA; D H CAMPBELL
Journal:  J Exp Med       Date:  1959-02-01       Impact factor: 14.307

8.  The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon.

Authors:  C G COCHRANE; W O WEIGLE
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307
  8 in total
  10 in total

1.  INHIBITION OF COMPLEMENT BY CARRAGEENIN: MODE OF ACTION, EFFECT ON ALLERGIC REACTIONS AND ON COMPLEMENT OF VARIOUS SPECIES.

Authors:  G E DAVIES
Journal:  Immunology       Date:  1965-03       Impact factor: 7.397

2.  The inflammatory response.

Authors:  W G SPECTOR; D A WILLOUGHBY
Journal:  Bacteriol Rev       Date:  1963-06

3.  Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

4.  Plasma kinin formation by complexes of aggregated gamma-globulin and serum proteins.

Authors:  V Eisen; H G Smith
Journal:  Br J Exp Pathol       Date:  1970-06

5.  The interaction of Hageman factor and immune complexes.

Authors:  C G Cochrane; K D Wuepper; B S Aiken; S D Revak; H L Spiegelberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

6.  Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

Authors:  L R Shoemaker; S J Schurman; V H Donaldson; A E Davis
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

7.  PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM.

Authors:  G E DAVIES; J S LOWE
Journal:  Br J Pharmacol Chemother       Date:  1963-12

8.  Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; S Reynia; M Robinson; A Shock; T J Williams; F M Williams; A G Rossi; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.

Authors:  O D RATNOFF; I H LEPOW
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

10.  INCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN.

Authors:  O D Ratnoff
Journal:  J Exp Med       Date:  1965-10-31       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.